Tretinoin NDC 50090-3128

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-3128Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-3128Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-3128-0	50090312800	1 TUBE in 1 CARTON (50090-3128-0) / 20 g in 1 TUBEMarketed from Aug 29, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tretinoin
Generic name (nonproprietary): tretinoin
Active ingredients: Tretinoin — .25 mg/g
Dosage form: Cream
Route: Topical
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075264
Marketing start: Jun 15, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 50090-3128_751edf37-8105-49e3-8621-475a5543193bSPL ID 751edf37-8105-49e3-8621-475a5543193bSPL set ID 0a6722ba-c2e5-4d7a-82ea-bcd6a54033b5RxCUI 106302, 106303, 198300UNII 5688UTC01R
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090312800 followed by a unit qualifier and the quantity

Package 50090-3128-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2024.

Indications (excerpt from the label)

Indications and Usage: Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075264

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075264
Product	Strength	Form · route	Labeler	Product NDC
Tretinoin	Tretinoin .25 mg/g	CreamTopical	Bryant Ranch Prepack	72162-2135
Tretinoin	Tretinoin .25 mg/g	CreamTopical	Padagis US LLC	0574-2225
Tretinoin	Tretinoin .25 mg/g	CreamTopical	NuCare Pharmaceuticals,Inc.	68071-3945
Tretinoin	Tretinoin .25 mg/g	CreamTopical	Preferred Pharmaceuticals Inc.	68788-4069